The efficacy and safety of moclobemide compared to clomipramine in the treatment of panic disorder

European Archives of Psychiatry and Clinical Neuroscience

Volumn 249, Issue SUPPL., 1999, Pages

  Krüger, Marit Bjartveit ^a   Dahl, Alv A ^a  

^a Innherred Hospital   (Norway)

Author keywords

Clomipramine; Drug treatment; Moclobemide; Panic disorder

Indexed keywords

CLOMIPRAMINE; MOCLOBEMIDE; SEROTONIN UPTAKE INHIBITOR;

ADULT; ANTICHOLINERGIC EFFECT; ARTICLE; ATAXIA; CLINICAL TRIAL; CONSTIPATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; FEMALE; HEADACHE; HUMAN; INSOMNIA; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NAUSEA; PANIC; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SOMNOLENCE; SWEATING; TREATMENT OUTCOME; VERTIGO; VISUAL IMPAIRMENT; XEROSTOMIA;

ADULT; AGED; BENZAMIDES; CHI-SQUARE DISTRIBUTION; CHRONIC DISEASE; CLOMIPRAMINE; FEMALE; HUMANS; MALE; MIDDLE AGED; MOCLOBEMIDE; MONOAMINE OXIDASE INHIBITORS; PANIC DISORDER; SEROTONIN UPTAKE INHIBITORS; TREATMENT OUTCOME;

EID: 17144472781     PISSN: 09401334     EISSN: None     Source Type: Journal    
DOI: 10.1007/PL00014163     Document Type: Article

References (17)

1. Ballenger JC, Wheadon DE, Steiner M et al. (1988) Doubleblind- fixed-dose, placebo-controlled study of paroxetine in the treatment of panic disorder. Am J Psychiatry 155: 36-42
2. Cassano GB, Petracca A, Perugi et al. (1988) Clomipramine for panic disorder. I. The first 10 weeks of a long-term comparison with imipramine. J Affect Disord 14: 123-127
3. Gorman J, Wolokow R (1994) Sertraline a treatment for panic disorder. Neuropsychopharmacology 10: 197S
4. Guy W (1976) Early Clinical Drug Evaluation Unit (ECDEU) assessment manual. US Department of Health, Education and Welfare, Washington, D.C., pp 217-222
5. Hamilton M (1959) The assessment of anxiety states by rating. Br J Med Psychol 32: 50-55
6. Hoehn-Saric R, McLeod DR, Hipsley PA (1993) Effect of flivoxamine on panic disorder. J Clin Psychopharmacol 13: 321-326
7. Katschnig H, Stein MB, Buller R (1997) Modobemide in social phobia. A double-blind, placebo-controlled clinical study. Eur Arch Psychiatry Clin Neurosci 247: 71-80
8. Leon AC, Shear MK, Portera L et al. (1992) Assessing impairment in patients with panic disorder: the Sheehan disability Scale. Soc Psychiatr Epidemiol 27: 78-82
9. Modigh K, Westberg A, Eriksson E (1992) Superiority of clomipramine over imipramine in the treatment of panic disorder: a placebo controlled trial. J Clin Psychopharmacol 12: 251-261
10. Montgomery SA, Asberg M (1979) A new depression scale designed to be sensitive to change. Br J Psychiatry 134: 382-389
11. Pélissolo A, Lépine J-P (1997) Psychopharmacological approaches to the treatment of anxiety disorders: a critical review and practical guidelines. In: de Boer JA (ed) Clinical management of anxiety. Marcel Dekker, New York, Basel, Hongkong, pp 249-294
12. Piantadosi S (1997) Clinical trials. A methodological perspective. Wiley, New York, Chichester, Weinheim, Brisbane, Singapore, Toronto
13. Pohl R, Yeragani V, Balon R et al. (1988) The jitteriness syndrome in panic disorder patients treated with antidepressants. J Clin Psychiatry 49: 100-104
14. Schneier FR, Liebowitz MR, Davies SO et al. (1990) Fluoxetine in panic disorder. J Clin Psychopharmacol 10: 119-121
15. Stabl M, Bizière K, Schraid-Burgk W et al. (1989) Review of comparative clinical trials: Moclobemide vs tricyclic antidepressants, and vs placebo in depressive states. J Neural Transm 28: suppl 77-90
16. Stein MB, Hazen AL, Eldridge GD et al. (1992) Structured clinical interview for DSM-III-R, revised for use in Hoffmann-La Roche moclobemide anxiety disorders program (SCID-Ro). The anxiety disorders research program, University of Manitoba, Manitoba, Canada
17. Tiller JWG, Bouwer C, Behnke K (1997) Moclobemide for anxiety disorder: a focus on moclobemide for panic disorder. Int Clin Psychopharmacol 12, suppl 6: S25-S28